I believe that what's on the website was originally done with a private company mindset perspective. I think some of that will change if the decision is made to bring ViroSense into EGYF via Datatecnics Meditech, Ltd.
In my opinion, they must see the value of each share for £1.00 to be considered a discounted price for the value of where they believe it will be worth in the future. For inquiring minds...